DE60029243D1 - Transfektion and aktivierung von dendritischen zellen durch mikropartikel - Google Patents

Transfektion and aktivierung von dendritischen zellen durch mikropartikel

Info

Publication number
DE60029243D1
DE60029243D1 DE60029243T DE60029243T DE60029243D1 DE 60029243 D1 DE60029243 D1 DE 60029243D1 DE 60029243 T DE60029243 T DE 60029243T DE 60029243 T DE60029243 T DE 60029243T DE 60029243 D1 DE60029243 D1 DE 60029243D1
Authority
DE
Germany
Prior art keywords
dendritic cells
microparticles
transfection
activation
transfection agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029243T
Other languages
English (en)
Other versions
DE60029243T2 (de
Inventor
James Donnelly
Sue Denis-Mize
Steven Ott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
CHIRON CORP (N D GES D STAATES DELAWARE)
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHIRON CORP (N D GES D STAATES DELAWARE), Chiron Corp filed Critical CHIRON CORP (N D GES D STAATES DELAWARE)
Application granted granted Critical
Publication of DE60029243D1 publication Critical patent/DE60029243D1/de
Publication of DE60029243T2 publication Critical patent/DE60029243T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
DE60029243T 1999-11-19 2000-11-17 Transfektion und aktivierung von dendritischen zellen durch mikropartikel Expired - Lifetime DE60029243T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16651499P 1999-11-19 1999-11-19
US166514P 1999-11-19
PCT/US2000/031776 WO2001036599A1 (en) 1999-11-19 2000-11-17 Microparticle-based transfection and activation of dendritic cells

Publications (2)

Publication Number Publication Date
DE60029243D1 true DE60029243D1 (de) 2006-08-17
DE60029243T2 DE60029243T2 (de) 2007-05-31

Family

ID=22603638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029243T Expired - Lifetime DE60029243T2 (de) 1999-11-19 2000-11-17 Transfektion und aktivierung von dendritischen zellen durch mikropartikel

Country Status (7)

Country Link
EP (1) EP1235900B1 (de)
JP (2) JP5597335B2 (de)
AT (1) ATE332361T1 (de)
AU (1) AU1623501A (de)
CA (1) CA2392071C (de)
DE (1) DE60029243T2 (de)
WO (1) WO2001036599A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753015B2 (en) 2000-09-28 2004-06-22 Chiron Corporation Microparticle compositions and methods for the manufacture thereof
EP1363663B1 (de) 2001-01-12 2011-03-02 Novartis Vaccines and Diagnostics, Inc. Nukleinsäure mukosale immunisierung
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
AU2003215316A1 (en) 2002-02-20 2003-09-09 Chiron Corporation Microparticles with adsorbed polypeptide-containing molecules
WO2004060396A2 (en) 2002-12-27 2004-07-22 Chiron Corporation Immunogenic compositions containing phospholpid
US20050191358A1 (en) * 2003-01-14 2005-09-01 Derek O' Hagan Microparticles with adsorbed polynucleotide-containing species
ES2328697T5 (es) 2003-06-02 2017-07-25 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunogénicas basadas en micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido
EP1991204A2 (de) 2006-02-24 2008-11-19 Novartis AG Mikropartikel mit biologisch abbaubarem polymer und kationischem polysaccharid zur verwendung für immunogene zusammensetzungen
WO2011149564A1 (en) 2010-05-28 2011-12-01 Tetris Online, Inc. Interactive hybrid asynchronous computer game infrastructure
ES2702318T3 (es) 2011-07-06 2019-02-28 Glaxosmithkline Biologicals Sa Emulsiones catiónicas de aceite en agua
RU2606846C2 (ru) 2011-07-06 2017-01-10 Новартис Аг Эмульсии типа "масло в воде", которые содержат нуклеиновые кислоты

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719316B1 (fr) * 1994-04-28 1996-05-31 Idm Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules.
EP0860167A1 (de) * 1997-01-30 1998-08-26 Robert Gurny DNA und RNA Wirkstoffderivate in Nanopartikeln

Also Published As

Publication number Publication date
JP2011062213A (ja) 2011-03-31
JP2003514522A (ja) 2003-04-22
DE60029243T2 (de) 2007-05-31
CA2392071C (en) 2012-01-10
EP1235900B1 (de) 2006-07-05
AU1623501A (en) 2001-05-30
EP1235900A1 (de) 2002-09-04
CA2392071A1 (en) 2001-05-25
JP5597335B2 (ja) 2014-10-01
WO2001036599A1 (en) 2001-05-25
ATE332361T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
DE60029243D1 (de) Transfektion and aktivierung von dendritischen zellen durch mikropartikel
ATE342969T1 (de) Ribozyme die fähig sind die expression des ccr5 rezeptor zu hemmen
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
ATE346156T1 (de) Umkehrtransfektionsverfahren
ATE426661T1 (de) Somatische pluripotente zellen
WO2001090345A3 (en) Methods and compositions for enhancing the delivery of a nucleic acid to a cell
AU2001283963A1 (en) Polysiloxane polymers, method for their production and the use thereof
BRPI0410616A (pt) xampu condicionador
WO2006071410A3 (en) Apparatus and system having dry gene silencing compositions
ATE351902T1 (de) Oberflächentransfektion und expressionsverfahren
TR199901616T2 (xx) S�v� suda a�artma bile�imleri ve �n-muamele i�lemi.
DE60103428D1 (de) Identifizierung von zellen während kinetischer versuchsreihen
ATE519772T1 (de) Vorrichtung und system mit trockener kontrollgen- verstummungszusammensetzung
TR200100027T2 (tr) Poliketidler, bunların hazırlanmaları ve kullanılan maddeler
CA2324887A1 (fr) Composition ophtalmique comprenant un .beta.-bloquant
GB2429887A (en) Controlling access message flow
DE60025639D1 (de) Substituierte diazepan
MX2007006585A (es) Composicion de adhesivo acuoso.
DE60323267D1 (en) Rna-bioassay
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
TR200200093T2 (tr) Gelişmiş mukavemet sergileyen poliüretan-üre lifler
ATE431876T1 (de) Verfahren zum beschleunigten abbau von mulchpapier, und mulchpapier
ITMI992535A0 (it) Procedimento per la produzione di polimeri vinilaromatici eventualment e contenenti un nitrile etilenicamente insaturo
DE60030270D1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
IT1312575B1 (it) Dispersioni acquose di polimeri.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., EMERYVILL

8364 No opposition during term of opposition